Physician profile
David A Mellul
NPI 1124061502
$2,315.11
in general payments reported to CMS, 2019-2025
15 companies · $568 in 2025
The $568 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $232 · 2022: $186 · 2023: $426 · 2024: $390 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $555.47 | 2019-2022 | |
| Orthofix Medical, INC. | $308.92 | 2024-2025 | Physio-Stim |
| Abbott Laboratories | $293.05 | 2023-2025 | Proclaim, Esprit |
| Averitas Pharma INC. | $249.98 | 2023-2024 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $156.58 | 2019-2023 | Jublia |
| Amgen INC. | $142.60 | 2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $124.99 | 2025 | Nuzyra |
| Inari Medical, INC. | $117.12 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zimmer Biomet Holdings, INC. | $105.87 | 2019 | |
| Nevro Corp. | $91.04 | 2023 | Senza |
| Grt US Holding, INC. | $74.79 | 2022 | |
| Epi Health, LLC | $58.01 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.04 | 2020 | |
| Merck Sharp & Dohme LLC | $11.56 | 2019 | |
| Vyne Pharmaceuticals INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mellul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.